Company Number: 12686403

Analysis Date: 2025-07-20 13:59 UTC

1. Credit Opinion: DECLINE
   DOCKRAY DEVELOPMENTS LTD exhibits significant financial weakness as of the latest year ending June 2024. The company’s net current liabilities have increased markedly from £1,202 to £3,330, and total net liabilities stand at £1,330, indicating a negative equity position. This deteriorating balance sheet signals an inability to meet short-term obligations reliably. The company’s micro-entity status and minimal asset base (£2,000 fixed assets, negligible current assets) further limit its collateral capacity. Given these factors, the company currently lacks the financial resilience and strength to support additional credit facilities without substantial improvement or guarantees.

2. Financial Strength:
   The balance sheet reveals a worrying trend: total assets less current liabilities have swung from a positive £798 in 2023 to a negative £1,330 in 2024. Fixed assets remain unchanged at £2,000, and current assets are negligible (£11), while current liabilities nearly triple. Net assets are negative, indicating shareholder funds have been eroded, which undermines the company’s solvency. The absence of significant retained earnings or capital injections and the sharp rise in short-term creditors suggest financial distress and poor capital structure.

3. Cash Flow Assessment:
   Current assets of £11 compared to current liabilities of £3,341 reflect severe liquidity constraints. The negative net current assets position (-£3,330) implies insufficient working capital to cover immediate debts, raising concerns about the company’s ability to maintain operations and meet creditor demands. The company's cash flow situation appears strained, with no evident buffer to absorb shocks or fund ongoing business activities without external support.

4. Monitoring Points:

• Monitor improvements in liquidity ratios (current ratio, quick ratio) and net working capital.
• Track changes in creditor balances and timing of repayments to evaluate cash flow management.
• Watch for capital injections or equity restructuring that could restore positive net assets.
• Review director and shareholder activity for signs of financial intervention or restructuring plans.
• Assess any changes in business strategy or operational scale that might impact financial health.